Loading financials from SEC filings…
Semiconductors · Technology · Fiscal year ends Jun 26
Synaptics reported revenue of $1.2B in the fiscal year ended Jun 2026, up 11.4% from the year before. Operating income was −$67M, an operating margin of −5.6%, and net income was −$491M. Operating cash flow of $149M less capital expenditure of $48M left free cash flow of $101M. Net debt was $395M.
Ranks among the 51 semiconductors companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 1,740 | 1,355 | 959 | 1,074 | 1,197 |
| Cost of revenue | 797 | 639 | 520 | 594 | 662 |
| Gross profit | 943 | 716 | 440 | 480 | 535 |
| Research & development | 367 | 351 | 336 | 347 | 382 |
| Selling, general & admin | 168 | 175 | 161 | 180 | 198 |
| Operating income | 350 | 154 | −102 | −94.1 | −67.1 |
| Interest expense | 30.2 | 55.5 | 65.3 | 39.8 | 23.4 |
| Pre-tax income | 321 | 126 | −125 | −114 | −79.4 |
| Income tax | 64.6 | 52.4 | −250 | −65.7 | 411 |
| Net income | 258 | 73.6 | 126 | −47.8 | −491 |
| Diluted EPS | 6.33 | 1.83 | 3.16 | −1.22 | −12.62 |
| Diluted shares | 0.0 | 40.2 | 39.7 | 39.3 | 38.9 |
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Cash & equivalents | 824 | 925 | 877 | 392 | 443 |
| Receivables | 322 | 164 | 142 | 130 | 164 |
| Inventory | 170 | 137 | 114 | 140 | 156 |
| Current assets | 1,403 | 1,272 | 1,162 | 752 | 787 |
| Net PP&E | 62.9 | 66.4 | 75.5 | 72.1 | 86.9 |
| Goodwill | 807 | 816 | 816 | 872 | 872 |
| Total assets | 2,858 | 2,611 | 2,825 | 2,584 | 2,102 |
| Payables | 142 | 45.8 | 87.5 | 98.5 | 82.6 |
| Deferred revenue | 27.3 | 18.7 | 14.7 | 16.2 | 1.7 |
| Current liabilities | 463 | 260 | 277 | 271 | 701 |
| Short-term debt | 6.0 | 6.0 | 6.0 | 0.0 | 440 |
| Long-term debt | 976 | 972 | 967 | 835 | 398 |
| Total liabilities | 1,592 | 1,368 | 1,358 | 1,190 | 1,173 |
| Shareholders' equity | 1,266 | 1,243 | 1,467 | 1,395 | 930 |
| Backlog (remaining obligations) | – | – | 0.0 | 0.0 | 0.0 |
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Operating cash flow | 463 | 332 | 136 | 142 | 149 |
| Capital expenditure | 31.1 | 34.2 | 33.8 | 25.8 | 48.0 |
| Free cash flow | 432 | 297 | 102 | 116 | 101 |
| Depreciation & amortisation | 24.0 | 27.4 | 27.6 | 28.9 | 30.8 |
| Stock-based compensation | 101 | 122 | 119 | 113 | 149 |
| Acquisitions | 501 | 15.5 | 0.0 | 201 | 0.0 |
| Share buybacks | 0.0 | 184 | 0.0 | 128 | 92.7 |
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | −22.1% | −29.2% | 12.0% | 11.4% |
| Operating income growth (YoY) | – | −56.0% | −165.8% | – | – |
| EPS growth (YoY) | – | −71.1% | 72.7% | −138.6% | – |
| Gross margin | 54.2% | 52.8% | 45.8% | 44.7% | 44.7% |
| Operating margin | 20.1% | 11.4% | −10.6% | −8.8% | −5.6% |
| Net margin | 14.8% | 5.4% | 13.1% | −4.4% | −41.0% |
| Return on equityBlank when equity is negative | 20.3% | 5.9% | 8.6% | −3.4% | −52.8% |
| ROCEEBIT ÷ (assets − current liabilities) | 14.6% | 6.6% | −4.0% | −4.1% | −4.8% |
| Free cash flow margin | 24.8% | 21.9% | 10.6% | 10.8% | 8.5% |
| Cash conversion (CFO ÷ net income) | 1.80x | 4.50x | 1.08x | −2.97x | −0.30x |
| Receivable days | 68 | 44 | 54 | 44 | 50 |
| Inventory days | 78 | 78 | 80 | 86 | 86 |
| Payable days | 65 | 26 | 61 | 61 | 46 |
| Interest cover | 11.6x | 2.78x | −1.56x | −2.36x | −2.87x |
| Debt ÷ equity | 0.78x | 0.79x | 0.66x | 0.60x | 0.90x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 158 | 53.3 | 96.0 | 443 | 395 |
| Current ratio | 3.03x | 4.89x | 4.19x | 2.78x | 1.12x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.